Hospital Clinic Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (28)

2024

  1. Improving the Access of Highly Sensitized Patients to Kidney Transplantation From Deceased Donors: The Spanish PATHI Program With Allocation Based on the Virtual Crossmatch

    Transplantation, Vol. 108, Núm. 3, pp. 787-801

2022

  1. Malignancies in Deceased Organ Donors: The Spanish Experience

    Transplantation, Vol. 106, Núm. 9, pp. 1814-1823

  2. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

2021

  1. Improved short-term outcomes of kidney transplants in controlled donation after the circulatory determination of death with the use of normothermic regional perfusion

    American Journal of Transplantation, Vol. 21, Núm. 11, pp. 3618-3628

  2. There Are 33,784 Functioning Kidney Grafts in Spain: Who Monitors Them and How?

    Transplantation Proceedings, Vol. 53, Núm. 9, pp. 2672-2674

2020

  1. Derivation and external validation of the SIMPLICITY score as a simple immune-based risk score to predict infection in kidney transplant recipients

    Kidney International, Vol. 98, Núm. 4, pp. 1031-1043

  2. Effectiveness and safety of the conversion to MeltDose® extended-release tacrolimus from other formulations of tacrolimus in stable kidney transplant patients: A retrospective study

    Clinical Transplantation, Vol. 34, Núm. 1

2018

  1. Vitamin D deficiency and infection risk in kidney transplant recipients: A single-center cohort study

    Transplant Infectious Disease, Vol. 20, Núm. 6

2016

  1. Mineral metabolism disorders, vertebral fractures and aortic calcifications in stable kidney transplant recipients: The role of gender (EMITRAL study)

    Nefrologia, Vol. 36, Núm. 3, pp. 255-267

2012

  1. Enteric-coated mycophenolate sodium in de novo and maintenance kidney-pancreas transplant recipients

    Clinical Transplantation, Vol. 26, Núm. 3, pp. 424-431

  2. Renal transplantation from donors with a positive serology for hepatitis C

    Contributions to Nephrology, Vol. 176, pp. 117-129

  3. Risk factors for graft loss and mortality after renal transplantation according to recipient age: A prospective multicentre study

    Nephrology Dialysis Transplantation, Vol. 27, Núm. SUPPL.4

  4. mTOR inhibitor-associated proteinuria in kidney transplant recipients

    Transplantation Reviews, Vol. 26, Núm. 1, pp. 27-29

2011

  1. Should we be using kidneys from hepatitis C virus-infected donors?

    Current Opinion in Nephrology and Hypertension, Vol. 20, Núm. 6, pp. 599-604

2010

  1. Long-term experience with kidney transplantation from hepatitis C-positive donors into hepatitis c-positive recipients

    American Journal of Transplantation, Vol. 10, Núm. 11, pp. 2453-2462

  2. Renal transplantation in patients with hepatitis C virus antibody. A long national experience

    NDT Plus, Vol. 3, Núm. SUPPLL. 2

2008

  1. Recomendaciones para la indicación, obtención, procesamiento y evaluación de biopsias en el trasplante renal

    Nefrologia, Vol. 28, Núm. 4, pp. 385-396

  2. Renal transplantation in the modern immunosuppressive era in Spain: Four-year results from a multicenter database focus on post-transplant cardiovascular disease

    Kidney International

2007

  1. Use of hepatitis C-positive donors for kidney transplantation

    Transplantation Reviews, Vol. 21, Núm. 4, pp. 195-203

2005

  1. Sirolimus-based therapy with or without cyclosporine: Long-term follow-up in renal transplant patients

    Transplantation Proceedings